Evolution of Biocatalysis at Novartis over the last 40 Years
DOI:
https://doi.org/10.2533/chimia.2023.376PMID:
38047776Keywords:
Biocatalysis, Bioinformatics, Enzyme evolution, Late-stage functionalization, Metabolite synthesisAbstract
The fortieth anniversary of biocatalysis started at Ciba-Geigy and later at Novartis is a great time to pause and reflect on development of science and technology in this field. Enzyme-based synthesis became a highly valued enabling tool for pharmaceutical research and development over the last decades. In this perspective we aim to discuss how the scientific approaches and trends evolved over the time and present future challenges and opportunities.
Downloads
Published
2023-06-28
Issue
Section
Scientific Articles
License
Copyright (c) 2023 Elina Siirola, Fabian Eggimann, Charles Moore, Kirsten Schroer, Alexandra Vargas, Theo Peschke, Thierry Schlama, Radka Snajdrova
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
[1]
Chimia 2023, 77, 376, DOI: 10.2533/chimia.2023.376.